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2-Pyridyl substituents enhance the activity of
palladium–phospha-adamantane catalysts for the
methoxycarbonylation of phenylacetylene†
Timothy A. Shuttleworth, Alexandra M. Miles-Hobbs, Paul G. Pringle* and
Hazel A. Sparkes
The synthesis of a series of CgPAr ligands is reported, where CgP is the 6-phospha-2,4,8-trioxa-1,3,5,7-
tetramethyladamant-6-yl moiety and Ar = 2-pyridyl (L2), 3-pyridyl (L3), 2-pyrimidyl (L4), 4-R-2-pyridyl
[R = Me (L5a), CF3 (L6a), SiMe3 (L7a)] or 6-R-2-pyridyl [R = Me (L5b), CF3 (L6b), SiMe3 (L7b). Testing of these
ligands in the Pd-catalysed methoxycarbonylation of phenylacetylene reveals that the activity and
branched selectivity of the catalysts derived from these ligands varies as a function of the N-heterocycle,
with the catalyst derived from L5b being the most active of those tested. This, together with the poor
performance of catalysts derived from L3 supports the hypothesis that the catalysis proceeds by a “proton
shuttling” mechanism, an idea that previously had only been applied to arylphosphines. Reaction of
[PtCl2(cod)] with L where L = L2 or L4–7 yields a rac/meso mixture of the trans-[PtCl2(L)2] (1a–h)
complexes, three of which are structurally characterised. 31P NMR spectroscopy shows that reaction of L3
with [PtCl2(cod)] gives a mixture of mononuclear and binuclear metal complexes in solution. The
complex trans-[PdCl2(L2)2] (4) reacts with AgBF4 to give the [PdCl(κ1-L2)(κ2-L2)]BF4 (5) with spectroscopic
and structural characterisation conﬁrming the presence of a P,N-chelate. 1H and 31P NMR evidence sup-
ports the assignment of a pyridyl-protonated species being formed upon treatment of 4 with TsOH·H2O
in CD2Cl2; both the protonated species and chelate 5 are observed when the reaction is carried out in
MeOH.
Introduction
The palladium-catalysed methoxycarbonylation of alkynes
(Scheme 1) is an atom-eﬃcient way of producing branched or
linear α,β-unsaturated esters from readily available feedstocks.1,2
The methoxycarbonylation of propyne (Scheme 1, R = Me)
has been extensively studied owing to the industrial interest in
the branched product, methyl methacrylate (MMA) which is a
precursor to poly(methyl methacrylate).3 The methoxy-
carbonylation of phenylacetylene (Scheme 1, R = Ph) produces
methyl atropate (branched product), a precursor to ibuprofen2
or methyl cinnamate (linear product), which has applications
in the perfume and flavouring industries.4
The activity, selectivity and stability of the palladium cata-
lyst for methoxycarbonylation depend critically on the ligand.
Drent et al. reported that changing the ligand from PPh3 to
Ph2P(2-py) (L1) led to an increase in rate of three orders of
magnitude for propyne and an increase in branched selectivity
from 89% to 99%.3 It was postulated that a “non-classical”
carbomethoxy mechanism involving P,N-chelates was in
operation and the greater catalyst activity was a result of the
Ph2P(2-py) acting as a “proton messenger”,
3 by bringing the
proton into close proximity to the metal and thereby promot-
ing the protonolysis of the proposed vinyl-palladium inter-
mediate as shown in Scheme 2.
Recently, Bühl et al. reported a computational study of
several possible pathways for methoxycarbonylation.5 Drent’s
original mechanism was challenged, as it was found that the
postulated, selectivity-determining transition state would
Scheme 1
†Electronic supplementary information (ESI) available: Crystal structures of
ligands L2–7 and crystal structure and refinement details. CCDC
1497885–1497898. For ESI and crystallographic data in CIF or other electronic
format see DOI: 10.1039/c6dt03983a
School of Chemistry, University of Bristol, Cantock’s Close, Bristol, BS8 1TS, UK.
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favour the formation of linear product (methyl crotonate) over
the branched product (MMA). Instead, an alternative cycle
involving labile P,N-chelates was proposed which proceeded by
an in situ base mechanism (Scheme 3)5 closely related to that
described by Scrivanti et al.6 This was suggested to be the
most plausible mechanism due to it having surmountable bar-
riers congruent with the high turnover and selectivity observed
experimentally with L1. Common to the Drent and Bühl
mechanisms (Schemes 2 and 3) is the chelation of the P,N
ligand which acts to stabilise the catalyst. Catalysts derived
from Ph2P(2-py) have been shown to be excellent for phenyl-
acetylene methoxycarbonylation (Scheme 1, R = Ph).3,6
It has also been observed that substituents on the 2-pyridyl
ring have a pronounced eﬀect upon the performance of the
catalyst; moreover Ph2P(3-py) and Ph2P(4-py) give catalysts of
much lower activity.3 Palladium complexes of other monophos-
phines with the potential to form heterodonor P,L-chelates
(e.g. pyrimidylphosphines,7 iminophosphines,8 phosphinoqui-
nilines,9 furylphosphines10 and so called TROPPs11) have been
shown to be eﬃcient methoxycarbonylation catalysts. It is
notable that in all of these ligands an Ar2P moiety is present.
12
Ligands incorporating the 6-phospha-2,4,8-trioxa-1,3,5,7-
tetramethyladamant-6-yl (CgP) moiety are eﬀective for a range
of Pd-catalysed carbonylation reactions.13 CgPR and tBu2PR
are comparable in terms of bulk but very diﬀerent in
σ/π-bonding characteristics: the donor properties of CgPR are
comparable to a (PhO)2PR.
14 It was therefore of interest to
investigate CgP(2-py) (L2) and its derivatives as ligands for
Pd-catalysed methoxycarbonylation of phenylacetylene. We
show here that the Pd–L2 catalysts are active and that 4- and
6-substituents on the 2-pyridyl aﬀect the performance of the
catalyst. The platinum and palladium coordination chemistry
of these ligands has been explored which has given some
insight into the function of L2 and related ligands.
Results and discussion
Ligand synthesis
The synthesis of CgP(2-py) (L2) has previously been reported
via a Pd-catalysed P-arylation of CgPH15 and we have extended
the route to the preparation of cage phosphines containing
3-pyridyl (L3), 2-pyrimidyl (L4), 4-substituted-2-pyridyl (L5–7a)
and 6-substituted-2-pyridyl (L5–7b) (Scheme 4). These air-stable
ligands were purified by column chromatography and have
been fully characterised. Crystals of all of the ligands L2–7 suit-
able for X-ray crystallography have been obtained. The struc-
tures are very similar to each other and so only L2, as a
representative structure, is shown in Fig. 1 along with its main
metrical parameters; the structures of L3–7 are given in the
ESI.†
Methoxycarbonylation catalysis
In order to draw comparisons in performance among the
ligands, the methoxycarbonylation of phenylacetylene (eqn (1))
has been carried out in the presence of L1–7, PPh3 and CgPPh
under the same reaction conditions and the results are pres-
ented in Table 1.
Scheme 2 Drent’s non-classical carbomethoxy mechanism.3
Scheme 3 Bühl’s in situ base mechanism.5
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Under the conditions we used for the catalysis, the PPh3
catalyst produced low and inconsistent conversions (entry 1)
ð1Þ
and at the end of the runs, copious amounts of black deposit,
presumably metallic palladium, was observed indicating that
the catalyst was not stable. As previously reported,4 the very
high activity of the catalyst derived from L1 (entry 3) contrasts
sharply with that of the isosteric PPh3 analogue (entry 1). The
CgPPh is superior to PPh3 in producing a moderately active
catalyst (entry 2) that shows no evidence of decomposition to
metallic Pd during the catalytic runs.
Ligand L2 (entry 4) produced a higher activity catalyst than
CgPPh (entry 3) indicating that the 2-pyridyl group has a posi-
tive eﬀect within the CgPAr series of ligands. This is reinforced
by the low activity observed with the 3-pyridyl isomer L3 (entry
11). The pyrimidyl group in ligand L4 (entry 12) led to a catalyst
with lower activity than L2.
The results for the catalysts derived from L5–7a and L5–7b
show that substituents Me, CF3 and SiMe3 at the 4- and 6-posi-
tions in the 2-pyridyl ring can, in some cases, have a signifi-
cant eﬀect on the conversion compared to the unsubstituted
L2. However, there appears to be no consistent trends associ-
ated with the stereoelectronic eﬀect of the substituents.
Relative to L2: (1) the 4-Me ligand L5a (entry 5) gives a signifi-
cantly lower conversion while the 6-Me ligand L5b (entry 6)
gives a significantly higher conversion; (2) the 4-CF3 and
4-SiMe3 ligands, L6a (entry 7) and L7a (entry 9), perform simi-
larly to L2 while the 6-CF3 and 6-SiMe3 ligands, L6b (entry 8)
and L7b (entry 10), produce catalysts of lower activity than L2.
In terms of branched selectivity, there is some evidence that
the 6-substituted 2-pyridyl ligands L5–7b give more branched-
selective catalysts than their 4-substituted isomers L5–7a
(entries 5–10). Others have reported similar observations with
4- and 6-substituted pyridyl derivatives of L1; that is, greater
branched selectivity was obtained with 6-substituted than with
4-substituted pyridyl ligands.4
In order to elucidate the function of the 2-pyridyl in the Pd-
catalysis, the coordination chemistry of L2–7 with Pt and Pd
has been investigated.
Coordination chemistry
Ligands L2–7 have been reacted with [PtCl2(cod)] (cod = 1,5-
cyclooctadiene) in CH2Cl2. With the exception of the reaction
with L3 (see below), products of the type trans-[PtCl2(L)2] (1a–h)
were obtained (Scheme 5) which have been fully characterised.
Scheme 4
Fig. 1 Crystal structure of L2. Hydrogen atoms omitted for clarity.
Thermal ellipsoids at 50% probability. Selected bond lengths (Å) and
bond angles (°): P1–C1 1.8857(12), P1–C4 1.8734(12), P1–C11 1.8395(12);
C1–P1–C4 92.71(5), C1–P1–C11 101.83(5), C4–P1–C11 106.34(5).
Table 1 Catalytic methoxycarbonylation of phenylacetylenea
Entry ligand
% Conversionb
% Branchedc4.5 h 1 h
1 PPh3 13 — 96
2 CgPPh 72 — 82
3 L1 100 100 99
4 L2 89 59 81
5 L5a 63 34 91
6 L5b 100 95 95
7 L6a 92 64 84
8 L6b 32 21 87
9 L7a 89 55 73
10 L7b 87 34 94
11 L3 14 — 99
12 L4 75 47 86
13 — <2 — —
a Reaction conditions: 5.5 mmol of phenylacetylene, 5.5 × 10−3 mmol
of Pd(OAc)2, 2.2 mmol of p-tolylsulfonic acid monohydrate, 1.1 mmol
of ligand, 1.5 cm3 of MeOH, 45 bar of CO, 60 °C. b Conversion and
selectivity determined by 1H NMR (see Experimental for details). Each
result is an average of 2 or more runs. c The rest of the product was the
linear isomer.
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The 31P NMR spectra of the products in each case showed two
closely spaced singlets with 195Pt satellites (1JP–Pt values are
typical of trans-[PtCl2(PR3)2] complexes) consistent with the
presence of rac and meso diastereomers resulting from the
chirality of the cage ligands.14
Crystals suitable for X-ray crystallography of 1c, 1d, 1e and
1g (meso isomers in each case) were grown by slow diﬀusion of
hexane into a CH2Cl2 solution of a rac/meso mixture of the
corresponding complex. As shown in Fig. 2–5, in each case,
the ligands adopt an anti conformation, with the C(pyridyl)–
P–P–C(pyridyl) torsion angle of 180°.
The reaction of [PtCl2(cod)] with the 3-pyridyl ligand L3 gave
diﬀerent results from those for all of the 2-pyridyl ligands L2,
and L4–7. The
31P NMR spectrum of the products of the reac-
tion of [PtCl2(cod)] with 2 equiv. of the 3-pyridyl ligand L3
showed four signals with 195Pt satellites, as well as free ligand
(δP −29.5 ppm). Two of the signals were assigned to rac/meso-
[PtCl2(L3)2] (1i) because of the similarity of their
31P NMR data
(δP −2.6 ppm, 1JP,Pt = 2703 Hz; δP −2.8 ppm, 1JP,Pt = 2710 Hz) to
those of the analogues 1a–h. The remaining two signals were
assigned to binuclear complexes of the type [Pt2Cl2(L3)2(μ-Cl)2]
on the basis of their large 1JP,Pt values (δP 8.3 ppm,
1JP,Pt = 4592
Hz; δP 7.9 ppm
1JP,Pt = 4608 Hz). Two types of isomerism (syn/
anti and rac/meso) would be expected for [Pt2Cl2(L3)2(μ-Cl)2]; in
view of the 0.4 ppm diﬀerence in their δP values, we tentatively
assign the two observed 31P NMR signals to syn- and anti-2
(Scheme 6) with the signals expected for the rac and meso
isomers unresolved. Mixtures of mononuclear and binuclear
products were also reported in the reaction of [PtCl2(cod)] with
2 equiv. CgPPh14 and so the observation of exclusive formation
of mononuclear complexes 1a–h appears to be an eﬀect of the
2-pyridyl group. It is tempting to associate this with weak
Pt⋯N interactions stabilising the mononuclear complexes
Scheme 5
Fig. 2 Crystal structure of meso-1c showing the anti–trans confor-
mation adopted by the ligands. Hydrogen atoms omitted for clarity.
Atoms suﬃxed with a dash (’) are related by symmetry operation (−x, −y,
−z). Thermal ellipsoids at 50% probability. Selected bond lengths (Å) and
angles (°): Pt1–Cl1 2.3125(7), Pt1–P1 2.3259(7), P1–C1 1.884(3), P1–C4
1.879(3), P1–C11 1.837(3); C1–P1–C4 94.10(13), C1–P1–C11 109.47(13),
C4–P1–C11 105.41(13).
Fig. 3 Crystal structure of meso-1d, showing the anti–trans confor-
mation adopted by the ligands. Hydrogen atoms omitted for clarity.
Atoms suﬃxed with a dash (’) are related by symmetry operation (−x,
1−y, −z). Thermal ellipsoids at 50% probability. Selected bond lengths (Å)
and angles (°): Pt1–Cl1 2.3119(6), Pt1–P1 2.3198(6), P1–C1 1.883(3),
P1–C4 1.878(3), P1–C11 1.845(3); C1–P1–C4 93.99(11), C1–P1–C11
103.98(12), C4–P1–C11 111.54(12).
Fig. 4 Crystal structure of meso-1e, showing the anti–trans confor-
mation adopted by the ligands. Hydrogen atoms omitted for clarity.
Atoms suﬃxed with a dash (’) are related by symmetry operation (−x,
1−y, −z). Thermal ellipsoids at 50% probability. Selected bond lengths (Å)
and angles (°): Pt1–Cl1 2.3056(5), Pt1–P1 2.3227(5), P1–C1 1.877(2),
P1–C4 1.886(3), P1–C11 1.842(2); C1–P1–C4 94.43(10), C1–P1–C11
105.04(13), C4–P1–C11 109.69(10).
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although in the solid state at least, no such interactions were
detected in complexes 1c–e and 1g (see Fig. 2–5).
The ability of 2-pyridylphosphines to switch between
P-monodentate and P,N-bidentate coordination has been
invoked as part of the explanation for the high activity of Pd-
complexes of 2-pyridylphosphines in methoxycarbonyla-
tion.3,5,6 It was therefore of interest to investigate if 2-pyridyl-
phosphine L2 could form 4-membered P,N-chelates. Treatment
of the trans complex 1a with 1 equiv. of AgBF4 gave a precipi-
tate of AgCl and a solution whose 31P{1H} NMR spectrum was
consistent with the formation of the monochelate 3[BF4]
(Scheme 7). Two doublets were observed at −48.1 ppm (1JP,Pt =
2728 Hz) and +0.8 ppm (1JP,Pt = 3514 Hz) with a small
2JP,P of
11 Hz typical of cis coordinated phosphines. The signal at
−48.1 ppm is assigned to the P,N-chelate since its high field
shift is characteristic of a 4-membered chelate.16 The lower
value of 1JP,Pt for the chelate-P is consistent with the ring strain
being relieved by lengthened Pt–P bonds; the crystal structure
of the Pd analogue 5[BF4] (see below) supports this inference.
In a similar manner to that described above for the Pt ana-
logues, reaction of [PdCl2(cod)] with 2 equiv. of L2 yielded
trans-[PdCl2(L2)2] (4) which has been fully characterised.
Treatment of 4 with 1 equiv. of AgBF4 gave a product assigned
the structure 5[BF4], the Pd analogue of 3[BF4] (Scheme 8).
Crystals of 5[BF4] suitable for X-ray crystallography were
obtained and its crystal structure determined (Fig. 6) which
confirmed the cis orientation of the two P-donors. The chelate
ring strain is apparent from the acute P–Pd–N angle of 69.0°.
The Pd–P length within the chelate is longer (by ca. 0.02 Å)
Scheme 6
Scheme 8
Fig. 5 Crystal structure of meso-1g, showing the anti–trans confor-
mation adopted by the ligands. Disordered atoms in CgP moiety and
hydrogen atoms omitted for clarity. Atoms suﬃxed with a dash (’) are
related by symmetry operation (1−x, −y, −z). Thermal ellipsoids at 50%
probability. Selected bond lengths (Å) and angles (°): Pt1–Cl1 2.3022(5),
Pt1–P1 2.3193(5), P1–C1 1.877(2), P1–C4 1.875(2), P1–C11 1.833(2); C1–
P1–C4 94.23(9), C1–P1–C11 103.66(8), C4–P1–C11 111.82(9).
Scheme 7
Fig. 6 Crystal structure of 5[BF4]. The [BF4]
− counterion, hydrogen
atoms and CH2Cl2 solvent molecule are omitted for clarity. Thermal
ellipsoids at 50% probability. Selected bond lengths (Å) and angles (°):
Pd1–Cl1 2.2989(10), Pd1–P1 2.3170(10), Pd1–P2 2.2779(10), Pd1–N1
2.073(3), P1–C11 1.829(4), P2–C26 1.819(4); P1–Pd1–P2 112.44(3), P1–
Pd1–N1 68.95(9), P1–C11–N1 101.9(3), P2–Pd1–Cl1 86.17(4), P1–Pd1–
Cl1 161.35(4), P2–Pd1–N1 176.87(9), C1–P1–C4 95.33(17), C16–P2–C19
94.48(16).
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than that for the monodentate ligand perhaps reflecting the
ring strain.
The 31P{1H} NMR spectrum of 5[BF4] in CHCl2CHCl2
showed a slightly broadened (w1/2 ∼ 8 Hz) signal at 28.8 ppm,
corresponding to the monodentate ligand, and a sharp
doublet at −42.7 ppm (2JP,P = 3.2 Hz), assigned to the P,N-
chelate. The signals remain distinct but broaden as the temp-
erature is raised (e.g. w1/2 ∼ 70 Hz at 100 °C in CHCl2CHCl2)
indicating that cation 5 is fluxional, which is associated with
intramolecular interchange of chelating and non-chelating P,N
ligands. Iggo et al. have shown that the complex [PdCl{κ1-Ph2P
(2-py)}{κ2-Ph2P(2-py)}]BF4 (an analogue of 5[BF4]) is fluxional
but with a coalescence temperature for the 31P NMR signals of
−30 °C which is at least 150 °C lower than for cation 5.17 The
high barrier to exchange in 5 can be rationalised in terms of
steric hindrance to Pd–P bond rotation which may be required
in order for the pyridyl-nitrogen in the κ1-L2 to coordinate.
Energy barriers to M–P bond rotation in complexes containing
cis-M(CgPH)2 moieties have previously been shown
18 to be of
the order of 50 kJ mol−1.
Complex 4 is only sparingly soluble in CD2Cl2 but
addition of 1.1 equiv. of TsOH·H2O to a suspension of 4 in
CD2Cl2 gave a homogenous yellow solution. The
31P NMR spec-
trum showed two broad peaks at 6.0 and 3.7 ppm (w1/2 ∼ 57 Hz
and 53 Hz respectively), which are tentatively assigned to
diastereoisomers of protonated species such as 6 (Scheme 9)
with rapid proton exchange rendering the 31P NMR signals
equivalent on the NMR timescale. In the 1H NMR spectrum of
6 a broad signal centred at 6.55 ppm is assigned to the exchan-
ging N–H. When a suspension of 4 in MeOH was treated with
TsOH, the 31P NMR spectrum of the resulting solution dis-
played two broad signals at 6.3 and 4.5 ppm (assigned to 6)
but in addition, two signals at 28.8 and −42.2 ppm are
present, suggesting that the P,N-chelate 5[OTs] is also gener-
ated (Scheme 9).
The Pd and Pt coordination chemistry of L2 has shown that
the ligand can be monodentate (κ1) or chelating (κ2) and the
pyridyl-N can be protonated by TsOH. These properties are
essential for the catalyst to be able to function in a manner
similar to L1 shown in Schemes 1 and 2. Tellingly, the
31P{1H}
NMR spectrum of the mixture obtained after catalysis runs
involving Pd and L2 showed, amongst other peaks, a promi-
nent signal at −37.8 ppm, reminiscent of the peak observed at
−42.1 ppm for the cation 5, suggesting that a four-membered
Pd chelate is present.
Conclusions
A series of substituted pyridyl-functionalised phospha-ada-
mantyl ligands L2–7 have been made and fully characterised. It
was found that, in some cases, substituents on the pyridyl ring
had a marked eﬀect on the rate of Pd-catalysed methoxycarbo-
nylation of phenylacetylene. The 6-methyl substituted ligand
L5b showed good activity and selectivity for the branched
product albeit lower than that of the well-known Ph2P(2-py)
(L1). The catalytic performance is a function of the substitu-
ents on the pyridine consistent with the idea that a mechan-
ism involving P,N-chelation and “proton shuttling” may be
operating.
The Pt and Pd coordination chemistry of L2–7 has been
probed and the ability of the ligands to form P,N-chelates has
been established in solution from the characteristic 31P NMR
spectra and in the solid state by the crystal structure of a palla-
dium complex containing L2 ligands bound in a κ1- and
κ2-mode. Moreover protonation of the pyridyl-N in a Pd-L2
complex has been observed in solution. In contrast to the
CgP(2-py) ligands, the CgP(3-py) ligand L3 gives binuclear
Pt complexes in a similar fashion to the CgPPh.
The methoxycarbonylation activity with catalysts derived
from CgP(2-py) and its derivatives demonstrates that the
2-pyridyl eﬀect is not restricted to Ph2P(2-py) and its deriva-
tives. The CgP and Ph2P moieties has very diﬀerent stereoelec-
tronic eﬀects and therefore the results presented hold out the
prospect that other R2P(2-py) ligands may be useful for alkyne
methoxycarbonylation catalysis.
Experimental
General procedures
All reactions were carried out under an atmosphere of dry
nitrogen, unless otherwise stated, using standard Schlenk line
techniques and oven dried (200 °C) glassware. CH2Cl2 and
hexane were collected from a Grubbs type solvent purification
system, and deoxygenated by bubbling with N2 for 30 minutes.
Xylene and CD2Cl2 were dried over activated 4 Å molecular
sieves for 72 hours and deoxygenated by successive freeze–
pump–thaw cycles. MeOH was purchased as anhydrous, stored
over 3 Å molecular sieves and deoxygenated by bubbling with
N2 for 30 minutes. Other commercial reagents were used as
supplied unless otherwise stated. [PtCl2(cod)],
19 [PdCl2(cod)],
20
1,3,5,7-tetramethyl-4,6,8-trioxa-2-phospha-adamantane (CgPH),21
CgPPh,14 Ph2P(2-py)
22 (L1) 2-bromo-4-(trimethylsilyl)pyridine,
23
and 2-bromo-6-(trimethylsilyl)pyridine24 were synthesised accord-Scheme 9
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ing to literature procedures. 1H, 11B, 13C, 19F and 31P NMR
spectra were recorded at ambient temperature unless otherwise
stated, on Jeol ECP (Eclipse) 300, Jeol ECS 300, Jeol ECS 400,
Varian 400-MR, Varian VNMRS 500 spectrometers and a Bruker
Avance III HD 500 spectrometer equipped with a 13C-observe
(DCH) cryogenic probe. Chemical shifts δ are given in parts per
million (ppm) and coupling constants J are in Hz. 1H and 13C
chemical shifts were referenced to residual solvent peaks. 11B, 19F
and 31P chemical shifts were referenced to BF3·OEt2, CFCl3 and
85% H3PO4 respectively. Mass Spectra were recorded by the
University of Bristol Mass Spectrometry Service on VG Analytical
Autospec (EI) or VG Analytical Quattro (ESI) spectrometers.
Elemental Analysis was carried out by the Microanalytical
Laboratory of the School of Chemistry, University of Bristol. X-ray
crystallography was performed by the University of Bristol X-ray
Analytical Service using Bruker AXS Microstar or Bruker Kappa
Apex II diﬀractometers. Thin Layer Chromatography (TLC) was
performed using Merck Kieselgel 60 F254 (Merck) aluminium
backed plates (0.25 mm layer of silica). Flash column chromato-
graphy was performed using a Biotage Isolera Spektra One
Chromatographic Isolation system.
General procedure for the synthesis of pyridyl-functionalised
phospha-adamantyl ligands. A Schlenk flask was charged with
a suspension of CgPH (1 equiv.), K2CO3 (3 equiv.) and
[Pd(PPh3)4] (3 mol%) in xylene (6 cm
3). The desired ArBr
(1.2 equiv.) was added and the mixture heated to 110 °C and
stirred for 24 h. The mixture was then allowed to cool and, in
air, passed through silica, eluting with Et2O. Removal of the
solvents in vacuo yielded the crude product.
CgP(2-py) (L2). Prepared according to a literature pro-
cedure.14 Crystals suitable for X-ray diﬀraction were grown by
slow diﬀusion of hexane into a CH2Cl2 solution of the product.
Spectroscopic data the same as those reported.
CgP(3-py) (L3). Purification by flash column chromatography
(20% EtOAc/hexane) yielded the product as a white solid
(0.432 g, 71%). Crystals suitable for X-ray diﬀraction were
grown by slow diﬀusion of hexane into a CH2Cl2 solution of
the product. 1H NMR (400 MHz, CDCl3): δH 8.93–8.92 (m, 1H,
ArH (H-2)), 8.61–8.59 (m, 1H, ArH (H-6)), 8.19–8.15 (m, 1H,
ArH (H-4)), 7.31–7.26 (m, 1H, ArH (H-5)), 2.05 (dd, 2JH,H =
13.3 Hz, 3JH,P = 7.3 Hz, 1H, CgP CH2), 1.94 (dd,
3JH,P = 25.1 Hz,
2JH,H = 13.3 Hz, 1H, CgP CH2), 1.66 (d,
2JH,H = 13.5 Hz, 1H, CgP
CH2), 1.51 (dd,
2JH,H = 13.4 Hz,
3JH,P = 4.3 Hz, 1H, CgP CH2),
1.49 (d, 3JH,P = 12.8 Hz, 3H, CgP CH3), 1.41 (s, 6H, CgP CH3),
1.25 (d, 3JH,P = 13.3 Hz, 3H, CgP CH3).
13C{1H} NMR (101 MHz,
CDCl3): δC 155.6 (d,
2JC,P = 26.4 Hz, ArC (C-2)), 150.5 (s, ArC
(C-6)), 142.3 (d, 2JC,P = 14.5 Hz, ArC (C-4)), 130.6 (d,
1JC,P =
32.4 Hz, ArC (C-3)), 123.6 (d, 3JC,P = 4.4 Hz, ArC (C-5)), 97.0 (s,
CgP quat. C), 96.2 (s, CgP quat. C), 73.3 (d, 1JC,P = 21.6 Hz, CgP
quat. C), 73.2 (d, 1JC,P = 7.3 Hz, CgP quat. C), 45.3 (d,
2JC,P =
17.7 Hz, CgP CH2), 36.4 (d,
2JC,P = 1.9 Hz, CgP CH2), 28.1 (s,
CgP CH3), 27.9 (s, CgP CH3), 27.5 (d,
2JC,P = 22.2 Hz, CgP CH3),
26.9 (d, 2JC,P = 11.1 Hz, CgP CH3).
31P{1H} NMR (162 MHz,
CDCl3): δP −29.5 (s, CgP). HRMS (EI): m/z calc. for C15H20NO3P
[M]+ = 293.1184; obs. = 283.1174. Elem. Anal. found (calc. for
C15H20NO3P): C, 61.78 (61.43); H, 6.94 (6.87); N, 5.00 (4.78).
CgP(2-pyrm) (L4). Purification by flash column chromato-
graphy (20% EtOAc/hexane) yielded the product as a white
solid (0.679 g, 80%). Crystals suitable for X-ray diﬀraction were
grown by slow evaporation of a CH2Cl2 solution of the product.
1H NMR (500 MHz, CDCl3): δH 8.69 (d,
3JH,H = 4.9 Hz, 2H, ArH
(H-4 and H 6)), 7.13 (t, 3JH,H = 4.9 Hz, 1H, ArH (H-5)), 2.19 (d,
2JH,H = 13.3 Hz, 1H, CgP CH2), 2.14 (dd,
2JH,H = 13.1 Hz,
3JH,P =
6.7 Hz, 1H, CgP CH2), 1.92 (dd,
3JH,P = 25.2 Hz,
2JH,H = 13.3 Hz,
1H, CgP CH2), 1.78 (d,
3JH,P = 12.0 Hz, 3H, CgP CH3), 1.72 (d,
3JH,P = 12.7 Hz, 3H, CgP CH3), 1.66 (dd,
2JH,H = 13.3 Hz,
3JH,P =
4.7 Hz, 1H, CgP CH2), 1.42 (s, 3H, CgP CH3), 1.27 (s, 3H, CgP
CH3).
13C{1H} NMR (126 MHz, CDCl3): δC 174.8 (d,
1JC,P =
9.7 Hz, ArC (C-2)), 156.1 (d, 2JC,P = 5.0 Hz, ArC (C-4 and C-6)),
119.3 (s, ArC (C-5)), 96.6 (s, CgP quat. C), 96.4 (s, CgP quat. C),
74.4 (d, 1JC,P = 24.8 Hz, CgP quat. C), 73.9 (d,
1JC,P = 6.9 Hz,
CgP quat. C), 45.6 (d, 2JC,P = 17.1 Hz, CgP CH2), 38.5 (d,
2JC,P =
1.9 Hz, CgP CH2), 28.7 (d,
2JC,P = 19.3 Hz, CgP CH3), 28.1 (s,
CgP CH3), 27.9 (s, CgP CH3), 27.6 (d,
2JC,P = 10.2 Hz, CgP CH3).
31P{1H} NMR (162 MHz, CDCl3): δP −18.5 (s, CgP). HRMS (EI):
m/z calc. for C14H19N2O3P [M]
+ = 294.1133; obs. = 294.1137.
Elem. Anal. found (calc. for C14H19N2O3P): C, 57.10 (57.14); H,
6.53 (6.51); N, 9.33 (9.52).
CgP(4-Me-2-py) (L5a). Purification by flash column chromato-
graphy (40% diethyl ether/hexane) yielded the product as a
white solid (0.343 g, 74%). Crystals suitable for X-ray diﬀrac-
tion were grown by slow diﬀusion of hexane into a CH2Cl2
solution of the product. 1H NMR (400 MHz, CDCl3): δH 8.53 (d,
3JH,H = 5.0 Hz, 1H, ArH (H-6)), 7.77 (s, 1H, ArH (H-3)), 7.02 (d,
3JH,H = 5.0 Hz, 1H, ArH (H-5)), 2.34 (s, 3H, Ar–CH3), 2.07 (dd,
2JH,H = 13.2 Hz,
3JH,P = 6.7 Hz, 1H, CgP CH2), 1.91 (dd,
3JH,P =
23.4 Hz, 2JH,H = 13.3 Hz, 1H, CgP CH2), 1.83 (d,
2JH,H = 13.2 Hz,
1H, CgP CH2), 1.57 (d,
3JH,P = 12.4 Hz, 3H, CgP CH3), 1.50 (dd,
2JH,H = 13.3 Hz,
3JH,P = 4.1 Hz, 1H, CgP CH2), 1.41 (s, 3H, CgP
CH3), 1.40 (d,
3JH,P = 12.4 Hz, 3H, CgP CH3), 1.37 (s, 3H, CgP
CH3).
13C{1H} NMR (101 MHz, CDCl3): δC 160.4 (d,
1JC,P = 12.7
Hz, ArC (C-2)), 149.9 (d, 3JC,P = 14.2 Hz, ArC (C-6)), 146.5 (d,
3JC,P = 1.8 Hz, ArC (C-4)), 130.2 (d,
2JC,P = 10.5 Hz, ArC (C-3)),
124.0 (s, ArC (C-5)), 96.9 (s, CgP quat. C), 96.3 (s, CgP quat. C),
73.5 (d, 1JC,P = 9.9 Hz, CgP quat. C), 73.1 (d,
1JC,P = 22.9 Hz,
CgP quat. C), 45.2 (d, 2JC,P = 16.7 Hz, CgP CH2), 37.5 (d,
2JC,P =
2.1 Hz, CgP CH2), 28.2 (s, CgP CH3), 28.0 (s, CgP CH3), 27.9 (d,
3JC,P = 20.6 Hz, CgP CH3), 27.3 (d,
3JC,P = 11.7 Hz, CgP CH3),
21.4 (s, Ar–CH3).
31P{1H} NMR (162 MHz, CDCl3): δP −24.5 (s,
CgP). HRMS (EI): m/z calc. for C16H22NO3P [M]
+ = 307.1337;
obs. = 307.1331. Elem. Anal. found (calc. for C16H22NO3P): C,
62.32 (62.53); H, 7.25 (7.22); N, 4.54 (4.56).
CgP(6-Me-2-py) (L5b). Purification by flash column chrom-
atography (5% EtOAc/hexane) yielded the product as a white
solid (0.578 g, 82%). Crystals suitable for X-ray diﬀraction were
grown by slow evaporation of a CHCl3 solution.
1H NMR
(400 MHz, CDCl3): δH 7.78 (d,
3JH,H = 7.7 Hz, 1H, ArH (H-3)),
7.51 (t, 3JH,H = 7.7 Hz, 1H, ArH (H-4)), 7.06 (d,
2JH,H = 8.2 Hz,
1H, ArH (H-5)), 2.54 (s, 3H, Ar–CH3), 2.07 (dd,
2JH,H = 13.2 Hz,
3JH,P = 6.7 Hz, 1H, CgP CH2), 1.89 (dd,
3JH,P = 23.1 Hz,
2JH,H =
13.2 Hz, 1H, CgP CH2), 1.82 (d,
2JH,H = 13.3 Hz, 1H, CgP CH2),
1.48 (dd, 2JH,H = 13.3 Hz,
3JH,P = 4.1 Hz, 1H, CgP CH2), 1.55
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(d, 3JH,P = 12.3 Hz, 3H, CgP CH3), 1.41 (d,
3JH,P = 12.5 Hz, 3H,
CgP CH3), 1.40 (s, 3H, CgP CH3), 1.35 (s, 3H, CgP CH3).
13C{1H}
NMR (126 MHz, CDCl3): δC 160.1 (d,
1JC,P = 10.7 Hz, ArC (C-6)),
158.9 (d, 3JC,P = 14.4 Hz, ArC (C-2)), 135.6 (d,
3JC,P = 1.2 Hz, ArC
(C-4)), 126.2 (d, 2JC,P = 8.4 Hz, ArC (C 3)), 122.6 (s, ArC (C-5)),
96.9 (s, CgP quat. C), 96.3 (s, CgP quat. C), 73.6 (d, 1JC,P =
9.9 Hz, CgP quat. C), 73.1 (d, 1JC,P = 22.9 Hz, CgP quat. C), 45.2
(d, 2JC,P = 16.7 Hz, CgP CH2), 37.6 (d,
2JC,P = 2.1 Hz, CgP CH2),
28.2 (s, CgP CH3), 28.0 (s, CgP CH3), 27.9 (d,
2JC,P = 20.4 Hz,
CgP CH3), 27.3 (d,
2JC,P = 11.8 Hz, CgP CH3), 24.3 (s, Ar–CH3).
31P{1H} NMR (162 MHz, CDCl3): δP −24.9 (s, CgP). HRMS (ESI):
m/z calc. for C16H23NO3P [M + H]
+ = 308.1410; obs. = 308.1404.
Elem. Anal. found (calc. for C16H22NO3P): C, 62.44 (62.53); H,
7.27 (7.22); N, 4.57 (4.56).
CgP(4-CF3-2-py) (L6a). Purification by flash column chrom-
atography (20% diethyl ether/hexane) yielded the product as a
white solid (0.673 g, 80%). Crystals suitable for X-ray diﬀrac-
tion were grown by slow diﬀusion of hexane into a CH2Cl2
solution of the product. 1H NMR (500 MHz, CDCl3): δH 8.88 (d,
3JH,H = 5.0 Hz, 1H, ArH (H-6)), 8.23 (s, 1H, ArH (H-3)), 7.43 (d,
3JH,H = 5.0 Hz, 1H, ArH (H-5)), 2.08 (dd,
2JH,H = 13.3 Hz,
3JH,P =
6.9 Hz, 1H, CgP CH2), 1.94 (dd,
3JH,P = 23.6 Hz,
2JH,H = 13.3 Hz,
1H, CgP CH2), 1.69 (d,
2JH,H = 13.4 Hz, 1H, CgP CH2), 1.59 (d,
3JH,P = 12.5 Hz, 3H, CgP CH3), 1.54 (dd,
2JH,H = 13.3 Hz,
3JH,P =
4.2 Hz, 1H, CgP CH2), 1.43 (s, 3H, CgP CH3), 1.42 (d,
3JH,P =
12.8 Hz, 3H, CgP CH3), 1.36 (s, 3H, CgP CH3).
13C{1H} NMR
(126 MHz, CDCl3): δC 163.5 (d,
1JC,P = 18.1 Hz, ArC (C-2)), 150.9
(d, 3JC,P = 13.1 Hz, ArC (C-6)), 137.8 (q,
2JC,F = 33.9 Hz, ArC
(C-4)), 124.8 (dq, 2JC,P = 10.0 Hz,
3JC,F = 3.5 Hz, ArC (C-3)),
122.9 (q, 1JC,F = 273.5 Hz, Ar–CF3), 118.4 (q,
3JC,F = 3.5 Hz, ArC
(C-5)), 97.0 (s, CgP quat. C), 96.3 (s, CgP quat. C), 73.6 (d, 1JC,P
= 9.7 Hz, CgP quat. C), 72.0 (d, 1JC,P = 22.8 Hz, CgP quat. C),
44.9 (d, 2JC,P = 16.5 Hz, CgP CH2), 37.6 (d,
2JC,P = 2.0 Hz, CgP
CH2), 28.0 (s, CgP CH3), 27.7 (s, CgP CH3), 27.8 (d,
2JC,P =
20.6 Hz, CgP CH3), 27.3 (d,
2JC,P = 11.4 Hz, CgP CH3).
19F NMR
(377 MHz, CDCl3): δF −64.8 (s, Ar–CF3). 31P{1H} NMR
(162 MHz, CDCl3): δP −24.2 (s, CgP). HRMS (EI): m/z calc. for
C16H19F3NO3P [M]
+ = 361.1055; obs. = 361.1057. Elem. Anal.
found (calc. for C16H19F3NO3P): C, 53.01 (53.19); H, 5.37 (5.30);
N, 3.96 (3.88).
CgP(6-CF3-2-py) (L6b). Purification by flash column chrom-
atography (10% EtOAc/hexane) yielded the product as a white
solid (0.633 g, 76%). Crystals suitable for X-ray diﬀraction were
grown by slow evaporation of a CH2Cl2 solution of the product.
1H NMR (400 MHz, CDCl3): δH 8.06 (d,
3JH,H = 7.9 Hz, 1H, ArH
(H-3)), 7.81 (t, 3JH,H = 8.2 Hz, 1H, ArH (H-4)), 7.58 (d,
3JH,H =
7.8 Hz, 1H, ArH (H-5)), 2.09 (dd, 2JH,H = 13.1 Hz,
3JH,P = 6.8 Hz,
1H, CgP CH2), 1.95 (dd,
3JH,P = 23.9 Hz,
2JH,H = 13.3 Hz, 1H,
CgP CH2), 1.94 (d,
2JH,H = 13.4 Hz, 1H, CgP CH2), 1.57 (d,
3JH,P
= 12.5 Hz, 3H, CgP CH3), 1.58–1.54 (m, 1H CgP CH2), 1.48 (d,
3JH,P = 12.8 Hz, 3H, CgP CH3), 1.42 (s, 3H, CgP CH3), 1.34 (s,
3H, CgP CH3).
13C{1H} NMR (126 MHz, CDCl3): δC 162.4 (d,
1JC,P = 21.0 Hz, ArC (C-2)), 148.6 (qd,
2JC,F = 34.6 Hz,
3JC,P =
10.8 Hz, ArC (C-6)), 136.6 (d, 3JC,P = 2.4 Hz, ArC (C-4)), 131.9 (d,
2JC,P = 13.7 Hz, ArC (C-3)), 121.5 (q,
1JC,F = 274.5 Hz, Ar–CF3),
119.4 (q, 3JC,F = 2.7 Hz, ArC (C-5)), 96.6 (s, CgP quat. C), 96.4 (s,
CgP quat. C), 73.8 (d, 1JC,P = 9.0 Hz, CgP quat. C), 73.1 (d,
1JC,P
= 23.3 Hz, CgP quat. C), 45.1 (d, 2JC,P = 16.9 Hz, CgP CH2), 37.7
(d, 2JC,P = 2.0 Hz, CgP CH2), 28.0 (s, CgP CH3), 27.9 (s, CgP
CH3), 27.8 (d,
2JC,P = 20.0 Hz, CgP CH3), 27.4 (d,
2JC,P = 11.4 Hz,
CgP CH3).
19F NMR (377 MHz, CDCl3): δF −68.1 (s, Ar–CF3). 31P
{1H} NMR (162 MHz, CDCl3): δP −23.6 (s, CgP). HRMS (EI): m/z
calc. for C16H19F3NO3P [M]
+ = 361.1055; obs. = 361.1058. Elem.
Anal. found (calc. for C16H19F3NO3P): C, 53.32 (53.19); H, 5.38
(5.30); N, 3.75 (3.88).
CgP(4-SiMe3-2-py) (L7a). Purification by flash column chrom-
atography (10% EtOAc/hexane) yielded the product as a white
solid (0.390 g, 56%). Crystals suitable for X-ray diﬀraction were
grown by slow evaporation of a CH2Cl2 solution of the product.
1H NMR (500 MHz, CDCl3): δH 8.64 (d,
3JH,H = 4.7 Hz, 1H, ArH
(H-3)), 8.11 (br s, 1H, ArH (H-6)), 7.30 (d, 3JH,H = 4.7 Hz, 1H,
ArH (H-5)), 2.10 (dd, 2JH,H = 13.3 Hz,
3JH,P = 6.6 Hz, 1H, CgP
CH2), 1.92 (dd,
3JH,P = 23.4 Hz,
2JH,H = 13.2 Hz, 1H, CgP CH2),
1.80 (d, 2JH,H = 13.3 Hz, 1H, CgP CH2), 1.57 (d,
3JH,P = 12.4 Hz,
3H, CgP CH3), 1.51 (dd,
2JH,H = 13.3 Hz,
3JH,P = 4.1 Hz, 1H, CgP
CH2), 1.42 (s, 3H, CgP CH3), 1.41 (d,
3JH,P = 12.6 Hz, 3H, CgP
CH3), 1.37 (s, 3H, CgP CH3), 0.32 (s, 9H, Si(CH3)3).
13C{1H}
NMR (126 MHz, CDCl3): δC 159.6 (d,
1JC,P = 13.5 Hz, ArC (C-2)),
149.8 (s, ArC (C-4)), 149.1 (d, 2JC,P = 13.4 Hz, ArC (C-3)), 133.9
(d, 3JC,P = 9.1 Hz, ArC (C-6)), 127.3 (s, ArC (C-5)), 96.9 (s, CgP
quat. C), 96.3 (s, CgP quat. C), 73.5 (d, 1JC,P = 9.7 Hz, CgP quat.
C), 73.1 (d, 1JC,P = 22.7 Hz, CgP quat. C), 45.2 (d,
2JC,P = 16.7
Hz, CgP CH2), 37.5 (d,
2JC,P = 2.1 Hz, CgP CH2), 28.2–27.8 (m,
CgP CH3), 27.3 (d,
2JC,P = 11.6 Hz, CgP CH3), 1.6 (s, Si(CH3)3).
31P{1H} NMR (162 MHz, CDCl3): δP −26.9 (s, CgP). HRMS (ESI):
m/z calc. for C18H29NO3PSi [M + H]
+ = 366.1649; obs. =
366.1662. Elem. Anal. found (calc. for C18H28NO3PSi): C, 59.55
(59.15); H, 7.89 (7.72); N, 4.02 (3.83).
CgP(6-SiMe3-2-py) (L7b). Purification by flash column chrom-
atography (10% EtOAc/hexane) yielded the product as a white
solid (0.424 g, 42%). Crystals suitable for X-ray diﬀraction were
grown by slow evaporation of a CH2Cl2 solution of the product.
1H NMR (400 MHz, CDCl3): δH 7.71 (d,
3JH,H = 7.9 Hz, 1H, ArH
(H-3)), 7.50 (t, 3JH,H = 7.7 Hz, 1H, ArH (H-4)), 7.38 (d,
3JH,H =
7.5 Hz, 1H, ArH (H-5)), 2.15 (d, 2JH,H = 13.2 Hz, 1H, CgP CH2),
2.10 (dd, 2JH,H = 13.2 Hz,
3JH,P = 6.5 Hz, 1H, CgP CH2), 1.91
(dd, 3JH,P = 23.5 Hz,
2JH,H = 13.2 Hz, 1H, CgP CH2), 1.57–1.51
(m, 3H, CgP CH3 and 1H CgP CH2), 1.47 (d,
3JH,P = 12.5 Hz,
3H, CgP CH3), 1.42 (s, 3H, CgP CH3), 1.33 (s, 3H, CgP CH3),
0.30 (s, 9H, Si(CH3)3).
13C{1H} NMR (126 MHz, CDCl3):
δC 167.0 (d,
3JC,P = 10.0 Hz, ArC (C-6)), 160.5 (d,
1JC,P = 13.4 Hz,
ArC (C-2)), 133.0 (d, 3JC,P = 3.2 Hz, ArC (C-4)), 128.4 (d,
2JC,P =
17.2 Hz, ArC (C-3)), 127.4 (s, ArC (C-5)), 96.9 (s, CgP quat. C),
96.4 (s, CgP quat. C), 73.7 (d, 1JC,P = 8.7 Hz, CgP quat. C), 73.2
(d, 1JC,P = 23.4 Hz, CgP quat. C), 45.3 (d,
2JC,P = 16.8 Hz, CgP
CH2), 37.7 (d,
2JC,P = 2.0 Hz, CgP CH2), 28.1 (s, CgP CH3), 28.0
(s, CgP CH3), 27.9 (d,
2JC,P = 19.9 Hz, CgP CH3), 27.4 (d,
2JC,P =
11.6 Hz, CgP CH3), 1.6 (s, Si(CH3)3).
31P{1H} NMR (162 MHz,
CDCl3): δP −26.9 (s, CgP). HRMS (ESI): m/z calc. for
C18H29NO3PSi [M + H]
+ = 366.1649; obs. = 366.1651. Elem.
Anal. found (calc. for C18H28NO3PSi): C, 59.29 (59.15); H, 7.79
(7.72); N, 3.87 (3.83). (The stability of this ligand was tested by
Paper Dalton Transactions
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heating in MeOH (ca. 0.5 cm3) with TsOH·H2O (2 equiv.) and
Pd(OAc)2 (0.1 equiv.) for 24 h and no decomposition was
observed.)
[PtCl2(L2)2] (1a). A solution of L2 (0.157 g, 0.537 mmol) in
CH2Cl2 (2 cm
3) was added to a solution of [PtCl2(cod)]
(0.100 g, 0.267 mmol) in CH2Cl2 (2 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.184 g, 81%). rac :meso compounds observed in 3 : 2 ratio. 1H
NMR (500 MHz, CD2Cl2): δH 8.76 (d,
3JH,H = 4.9 Hz) and 8.76
(d, 3JH,H = 4.9 Hz) (total 2H, ArH (H-6)), 8.04–8.01 (m, 2H, ArH
(H-3)), 7.70–7.64 (m, 2H, ArH (H-4)), 7.32–7.26 (m, 2H, ArH
(H-5)), 3.04 (dt, 2JH,H = 13.6 Hz, JH,P = 2.3 Hz) and 2.95 (dt,
2JH,H
= 13.6 Hz, JH,P = 2.3 Hz) (total 2H, CgP CH2), 1.98–1.86 (m, 3H,
CgP CH2), 1.85 (vir t, JH,P = 6.2 Hz) and 1.80 (vir t, JH,P = 6.2 Hz)
(total 6H, CgP CH3), 1.74 (vir t, JH,P = 6.7 Hz) and 1.69 (vir t,
JH,P = 6.7 Hz) (total 6H, CgP CH3), 1.66–1.59 (m, 1H, CgP CH2),
1.39 (s) and 1.34 (s) (total 6H, CgP CH3), 1.27 (s) and 1.26 (s)
(total 6H, CgP CH3).
13C{1H} NMR (126 MHz, CD2Cl2): δC 154.2
(vir t, JC,P = 154.1 Hz, ArC (C-2)), 149.6 (app q, JC,P = 8.4 Hz,
ArC (C-6)), 134.7 (app q, JC,P = 3.3 Hz, ArC (C-4)), 130.7 (app q,
JC,P = 8.3 Hz, ArC (C-3)), 123.9 (s, ArC (C-5)), 96.4–96.2 (m, CgP
quat. C), 74.9 (vir t, JC,P = 14.1 Hz) and 74.7 (vir t, JC,P =
14.1 Hz) (CgP quat. C), 73.8 (vir t, JC,P = 11.1 Hz) and 73.7
(vir t, JC,P = 11.1 Hz) (CgP quat. C), 42.2 (vir t, JC,P = 3.8 Hz) and
42.1 (vir t, JC,P = 3.8 Hz) (CgP CH2), 41.9–41.8 (m, CgP CH2),
27.9 (s, CgP CH3), 27.7 (s, CgP CH3), 27.6 (br s) and 27.2 (br s)
(CgP CH3), 26.0 (vir t, JC,P = 2.0 Hz) and 25.8 (vir t, JC,P = 2.5
Hz) (CgP CH3).
31P{1H} NMR (162 MHz, CD2Cl2): δP −0.6 (s,
1JP,Pt = 2740 Hz) and −1.1 (s, 1JP,Pt = 2727 Hz) (CgP). HRMS (ESI):
m/z calc. for C30H40ClN2O6P2Pt [M − Cl]+ = 816.1695; obs. =
816.1690. Elem. Anal. found (calc. for C30H40Cl2N2O6P2Pt): C,
42.64 (42.26); H, 5.13 (4.73); N, 3.44 (3.29).
[PtCl2(L4)2] (1b). A solution of L4 (0.033 g, 0.110 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.020 g, 0.053 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.043 g, 95%). rac :meso compounds observed in 1 : 1 ratio. 1H
NMR (500 MHz, CD2Cl2): δH 8.76 (d,
3JH,H = 4.9 Hz) and 8.75
(d, 3JH,H = 4.9 Hz) (total 4H, ArH (H-4 and H-6)), 7.25–7.22 (m,
2H, ArH (H-5)), 3.16 (d of vir t, 2JH,H = 13.7 Hz, JH,P = 1.8 Hz)
and 3.13 (d of vir t, 2JH,H = 13.6 Hz, JH,P = 2.3 Hz) (total 2H,
CgP CH2), 2.29 (d,
3JH,H = 13.8 Hz) and 2.21 (d,
3JH,H = 13.8 Hz)
(total 2H, CgP CH2), 1.92–1.83 (m, 12H, CgP CH3), 1.82–1.70
(m, 4H, CgP CH3), 1.37 (s) and 1.35 (s) (total 6H, CgP CH3),
1.20 (s, 6H, CgP CH3).
13C{1H} NMR (126 MHz, CD2Cl2):
δC 168.0 (vir t, JC,P = 46.1 Hz, ArC (C-2)), 156.2 (vir t, JC,P =
5.6 Hz) and 156.1 (vir t, JC,P = 5.6 Hz) (ArC (C-4 and C-6)), 121.3
(s, ArC (C-3)), 97.0 (s) and 96.96 (s) (CgP quat. C), 96.94 (s) and
96.92 (s) (CgP quat. C), 75.8–75.5 (m, CgP quat. C), 42.9–42.8
(m, CgP CH2), 42.6–42.4 (m, CgP CH2), 27.9 (s, CgP CH3), 27.7
(s) and 27.6 (s) (CgP CH3), 27.4 (vir t, JC,P = 2.4 Hz) and 27.3
(vir t, JC,P = 2.4 Hz) (CgP CH3), 26.7 (br s) and 26.6 (br s) (CgP
CH3).
31P{1H} NMR (162 MHz, CD2Cl2): δP −0.8 (s, 1JP,Pt = 2707
Hz) and −0.9 (s, 1JP,Pt = 2706 Hz) (CgP). HRMS (ESI): m/z calc.
for C28H38ClN4O6P2Pt [M − Cl]+ = 818.1600; obs. = 818.1606.
Elem. Anal. found (calc. for C28H38Cl2N4O6P2Pt): C, 39.66
(39.35); H, 4.57 (4.48); N, 6.34 (6.56).
[PtCl2(L5a)2] (1c). A solution of L5a (0.018 g, 0.058 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.010 g, 0.027 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.022 g, 86%). Crystals suitable for X-ray diﬀraction were
grown by slow diﬀusion of hexane into a CH2Cl2 solution of
the product. rac :meso compounds observed in 3 : 2 ratio.
1H NMR (500 MHz, CD2Cl2): δH 8.60 (d,
3JH,H = 5.0 Hz) and
8.58 (d, 3JH,H = 5.0 Hz) (total 2H, ArH (H-6)), 7.89 (br s) and
7.86 (br s) (total 2H, ArH (H-3)), 7.14 (d, 3JH,H = 4.7 Hz) and
7.10 (d, 3JH,H = 5.0 Hz) (total 2H, ArH (H-5)), 3.05 (d of vir t,
2JH,H = 13.6 Hz, JH,P = 2.1 Hz) and 2.95 (d of vir t,
2JH,H = 13.6
Hz, JH,P = 2.1 Hz) (total 2H, CgP CH2), 2.38 (s) and 2.35 (s)
(total 6H, Ar–CH3), 2.05–2.02 (m, 1H, CgP CH2), 1.98–1.88 (m,
2H, CgP CH2), 1.84 (vir t, JH,P = 6.2 Hz) and 1.80 (vir t, JH,P =
6.2 Hz) (total 6H, CgP CH3), 1.73 (vir t, JH,P = 6.6 Hz) and 1.68
(vir t, JH,P = 6.6 Hz) (total 6H, CgP CH3), 1.65–1.56 (m, 3H, CgP
CH2), 1.39 (s) and 1.34 (s) (total 6H, CgP CH3), 1.27 (s) and
1.26 (s) (total 6H, CgP CH3).
13C{1H} NMR (126 MHz, CD2Cl2):
δC 159.3 (vir t, JC,P = 34.6 Hz, ArC (C-2)), 149.8 (vir t, JC,P = 8.7
Hz) and 149.6 (vir t, JC,P = 8.7 Hz) (ArC (C-6)), 146.9–146.7 (br
s, ArC (C-4)), 132.2 (vir t, JC,P = 8.7 Hz) and 132.0 (vir t, JC,P =
8.7 Hz) (ArC (C-3)), 125.6 (s, ArC (C-5)), 96.9 (s, CgP quat. C),
96.8 (s) and 96.7 (s) (CgP quat. C), 75.5 (vir t, JC,P = 14.0 Hz)
and 75.3 (vir t, JC,P = 14.0 Hz) (CgP quat. C), 74.4 (vir t, JC,P =
11.1 Hz) and 74.3 (vir t, JC,P = 11.1 Hz) (CgP quat. C), 42.9 (app
q, JC,P = 4.1 Hz, CgP CH2), 42.4 (s) and 42.3 (s) (CgP CH2), 27.8
(s, CgP CH3), 27.64 (s) and 27.56 (s) (CgP CH3), 27.5 (br s) and
27.4 (br s) (CgP CH3), 26.1 (vir t, JC,P = 2.2 Hz) and 25.9 (vir t,
JC,P = 2.4 Hz) (CgP CH3), 21.7 (s) and 21.6 (s) (Ar–CH3).
31P{1H}
NMR (162 MHz, CD2Cl2): δP −0.6 (s, 1JP,Pt = 2738 Hz) and −1.0
(s, 1JP,Pt = 2729 Hz) (CgP). HRMS (ESI): m/z calc. for
C32H44ClN2O6P2Pt [M − Cl]+ = 844.2009; obs. = 844.1993.
Elem. Anal. found (calc. for C32H44Cl2N2O6P2Pt): C, 43.47
(43.64); H, 5.07 (5.04); N, 3.19 (3.18).
[PtCl2(L5b)2] (1d). A solution of L5b (0.017 g, 0.055 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.010 g, 0.027 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.020 g, 78%). Crystals suitable for X-ray diﬀraction were
grown by slow diﬀusion of hexane into a CH2Cl2 solution of
the product. rac :meso compounds observed in 3 : 2 ratio.
1H NMR (500 MHz, CD2Cl2): δH 7.87–7.84 (m, 2H, ArH (H-3)),
Dalton Transactions Paper
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7.58–7.53 (m, 2H, ArH (H-4)), 7.16–7.12 (m, 2H, ArH (H-5)),
3.09 (d of vir t, 2JH,H = 13.6 Hz, JH,P = 2.1 Hz) and 2.99 (d of vir
t, 2JH,H = 13.6 Hz, JH,P = 2.1 Hz) (total 2H, CgP CH2), 2.62 (s)
and 2.57 (s) (total 6H, Ar–CH3), 2.17 (d,
2JH,H = 13.7 Hz, 1H,
CgP CH2), 1.90–1.87 (m, 2H, CgP CH2) 1.85 1.70 (m, 12H, CgP
CH3), 1.64–1.60 (m, 3H, CgP CH2), 1.37 (s) and 1.34 (s) (total
6H, CgP CH3), 1.25 (s, 6H, CgP CH3).
13C{1H} NMR (126 MHz,
CD2Cl2): δC 159.3 (vir t, JC,P = 8.6 Hz) and 159.0 (vir t, JC,P = 8.6
Hz) (ArC (C-6)), 153.7 (vir t, JC,P = 34.8 Hz) and 153.6 (vir t, JC,P
= 35.6 Hz) (ArC (C-2)), 135.4–135.3 (m, ArC (C-4)), 128.7 (vir t,
JC,P = 9.3 Hz) and 128.5 (vir t, JC,P = 8.2 Hz) (ArC (C-3)), 124.2
(s) and 124.1 (s) (ArC (C-5)), 97.0 (s) and 96.9 (s) (CgP quat. C),
96.8 (s) and 96.7 (s) (CgP quat. C), 75.6 (vir t, JC,P = 14.0 Hz)
and 75.4 (vir t, JC,P = 14.0 Hz) (CgP quat. C), 74.5 (vir t, JC,P =
11.1 Hz) and 74.2 (vir t, JC,P = 11.1 Hz) (CgP quat. C), 42.9 (vir
t, JC,P = 3.8 Hz) and 42.7 (vir t, JC,P = 3.8 Hz) (CgP CH2), 42.5 (s)
and 42.4 (s) (CgP CH2), 27.9 (s, CgP CH3), 27.8 (s) and 27.6 (s)
(CgP CH3), 27.7 (br s) and 27.4 (br s) (CgP CH3), 26.4 (vir t, JC,P
= 2.4 Hz) and 26.0 (vir t, JC,P = 2.4 Hz) (CgP CH3), 24.8 (s) and
24.7 (s) (Ar–CH3).
31P{1H} NMR (162 MHz, CD2Cl2): δP −1.2 (s,
1JP,Pt = 2731 Hz) and −1.5 (s, 1JP,Pt = 2723 Hz) (CgP). HRMS
(ESI): m/z calc. for C32H44ClN2O6P2Pt [M − Cl]+ = 844.2009;
obs. = 844.2012. Elem. Anal. found (calc. for
C32H44Cl2N2O6P2Pt): C, 43.73 (43.64); H, 5.12 (5.04); N, 3.24
(3.18).
[PtCl2(L6a)2] (1e). A solution of L6a (0.020 g, 0.055 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.010 g, 0.027 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.019 g, 72%). Crystals suitable for X-ray diﬀraction were
grown by slow diﬀusion of hexane into a CH2Cl2 solution of
the product. rac :meso compounds observed in 3 : 1 ratio. 1H
NMR (500 MHz, CD2Cl2): δH 8.96 (d,
3JH,H = 5.0 Hz) and 8.93
(d, 3JH,H = 5.0 Hz) (total 2H, ArH (H-6)), 8.29 (br s) and 8.26 (br
s) (total 2H, ArH (H-3)), 7.53 (d, 3JH,H = 4.4 Hz) and 7.50 (d,
3JH,H
= 4.7 Hz) (total 2H, ArH (H-5)), 3.02 (d of vir t, 2JH,H =
13.7 Hz, JH,P = 2.3 Hz) and 2.93 (d of vir t,
2JH,H = 13.7 Hz, JH,P
= 2.4 Hz) (total 2H, CgP CH2), 1.98–1.86 (m, 4H, CgP CH2),
1.84–1.71 (m, 12H, CgP CH3), 1.69–1.67 (m, 2H, CgP CH2), 1.41
(s) and 1.36 (s) (total 6H, CgP CH3), 1.28 (s, 6H, CgP CH3).
13C{1H} NMR (126 MHz, CD2Cl2): δC 156.9 (vir t, JC,P = 33.7 Hz,
ArC (C-2)), 151.0 (vir t, JC,P = 8.2 Hz, ArC (C-6)), 137.3 (q of vir t,
2JC,F = 33.9 Hz, JC,P = 3.6 Hz, ArC (C-4)), 126.8–126.6 (m, ArC
(C-3)), 123.2 (q, 1JC,F = 273.5 Hz, Ar–CF3), 118.4 (q,
3JC,F =
3.5 Hz, ArC (C-5)), 97.0–96.9 (m, CgP quat. C), 75.7 (vir t,
JC,P = 14.0 Hz, CgP quat. C), 74.5 (vir t, JC,P = 11.0 Hz, CgP
quat. C), 42.6 (vir t, JC,P = 4.0 Hz, CgP CH2), 42.5 (s, CgP CH2),
27.9 (s, CgP CH3), 27.7 (s) and 27.6 (s) (CgP CH3), 27.5 (br s)
and 27.4 (br s) (CgP CH3), 26.0 (vir t, JC,P = 2.5 Hz) and 25.9
(vir t, JC,P = 2.5 Hz) (CgP CH3).
19F NMR (377 MHz, CD2Cl2):
δF −65.13 (s) and −65.16 (s) (Ar–CF3). 31P{1H} NMR (162 MHz,
CD2Cl2): δP 1.2 (s,
1JP,Pt = 2759 Hz) and 0.7 (s,
1JP,Pt = 2750 Hz)
(CgP). HRMS (ESI): m/z calc. for C32H38ClF6N2O6P2Pt [M − Cl]+
= 952.1443; obs. = 952.1479. Elem. Anal. found (calc. for
C32H38Cl2F6N2O6P2Pt): C, 38.66 (38.88); H, 3.89 (3.87); N, 2.85
(2.83).
[PtCl2(L6b)2] (1f). A solution of L6b (0.040 g, 0.110 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.020 g, 0.053 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as an oﬀ-white solid
(0.044 g, 84%). rac :meso compounds observed in 2 : 1 ratio. 1H
NMR (500 MHz, CD2Cl2): δH 8.30 (d,
3JH,H = 8.0 Hz) and 8.25
(d, 3JH,H = 8.0 Hz) (total 2H, ArH (H-3)), 7.90 (t,
3JH,H = 8.0 Hz)
and 7.85 (d, 3JH,H = 8.0 Hz) (total 2H, ArH (H-4)), 7.68 (d,
3JH,H
= 7.9 Hz) and 7.63 (d, 3JH,H = 7.9 Hz) (total 2H, ArH (H-5)), 3.08
(d of vir t, 2JH,H = 13.7 Hz, JH,P = 2.2 Hz) and 3.01 (d of vir t,
2JH,H = 13.8 Hz, JH,P = 2.2 Hz) (total 2H, CgP CH2), 2.16 (d,
2JH,H
= 13.8 Hz) and 2.14 (d, 2JH,H = 13.8 Hz) (total 2H, CgP CH2),
1.95–1.84 (m, 2H, CgP CH2), 1.78–1.68 (m, 14H, CgP CH3 and
CH2), 1.41 (s) and 1.36 (s) (6H, CgP CH3), 1.27 (br s, 6H, CgP
CH3).
13C{1H} NMR (126 MHz, CD2Cl2): δC 156.1 (vir t, JC,P =
32.0 Hz) and 156.0 (vir t, JC,P = 32.5 Hz) (ArC (C-2)), 148.1 (vir t,
JC,P = 7.3 Hz) and 147.8 (vir t, JC,P = 7.8 Hz) (ArC (C-6)), 136.7
(vir t, JC,P = 5.6 Hz, ArC (C-4)), 134.2 (vir t, JC,P = 9.5 Hz, ArC
(C-3)), 121.9 (q, 1JC,F = 274.0 Hz) and 121.8 (q,
1JC,F = 274.4 Hz)
(Ar–CF3), 121.2 (br s) and 121.1 (br s) (ArC (C-5)), 97.1 (s) and
97.05 (s) (CgP quat. C), 97.03 (s) and 96.9 (s) (CgP quat. C),
75.7 (vir t, JC,P = 14.4 Hz) and 75.6 (vir t, JC,P = 14.4 Hz) (CgP
quat. C), 74.8–74.5 (m, CgP quat. C), 42.7–42.6 (m, CgP CH2),
42.4 (s) and 42.3 (s) (CgP CH2), 27.8 (s, CgP CH3), 27.7 (s) and
27.6 (s) (CgP CH3), 27.2 (s) and 27.71 (s) (CgP CH3), 26.2 (br s,
CgP CH3).
19F NMR (470 MHz, CD2Cl2): δF −68.4 (s) and −68.5
(s) (Ar–CF3).
31P{1H} NMR (202 MHz, CD2Cl2): δP 0.2 (s,
1JP,Pt =
2756 Hz, CgP). HRMS (ESI): m/z calc. for
C32H38Cl2F6N2NaO6P2Pt [M + Na]
+ = 1010.1029; obs. =
1010.1027. Elem. Anal. found (calc. for C32H38Cl2F6N2O6P2Pt):
C, 38.92 (38.88); H, 4.08 (3.87); N, 2.75 (2.83).
[PtCl2(L7a)2] (1g). A solution of L7a (0.040 g, 0.110 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.020 g, 0.053 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.035 g, 66%). Crystals suitable for X-ray diﬀraction were
grown by slow diﬀusion of hexane into a CH2Cl2 solution of
the product. rac :meso compounds observed in 1 : 1 ratio. 1H
NMR (500 MHz, CD2Cl2): δH 8.69 (d,
3JH,H = 4.7 Hz) and 8.66
(d, 3JH,H = 4.7 Hz) (total 2H, ArH (H-3)), 8.19–8.17 (m) and
8.15–8.13 (m) (total 2H, ArH (H-6)), 7.40 (d, 3JH,H = 4.6 Hz) and
7.36 (d, 3JH,H = 4.7 Hz) (total 2H, ArH (H-5)), 3.07 (d of vir t,
2JH,H = 13.6 Hz, JH,P = 2.3 Hz) and 2.97 (d of vir t,
2JH,H =
13.6 Hz, JH,P = 2.3 Hz) (total 2H, CgP CH2), 2.04 (d,
2JH,H =
13.7 Hz) and 1.93 (d, 2JH,H = 13.5 Hz, 2H, CgP CH2), 1.92–1.85
(m, 2H, CgP CH2), 1.82 (vir t, JH,P = 6.2 Hz) and (vir t, JH,P =
6.1 Hz) (total 6H, CgP CH3), 1.72 (vir t, JH,P = 6.6 Hz) and 1.68
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(vir t, JH,P = 6.6 Hz) (total 6H, CgP CH3), 1.74–1.67 (m, 6H, CgP
CH3), 1.64–1.58 (m, 2H, CgP CH2), 1.40 (s) and 1.34 (s) (total
6H, CgP CH3), 1.26 (s) and 1.25 (s) (total 6H, CgP CH3), 0.30 (s)
and 0.28 (s) (total 18H, Si(CH3)3).
13C{1H} NMR (126 MHz,
CD2Cl2): δC 153.5 (vir t, JC,P = 33.7 Hz, ArC (C-2)), 149.8–149.7
(m, ArC (C-4)), 149.0–148.8 (m, ArC (C-3)), 135.7–135.5 (m, ArC
(C-6)), 128.9 (br s, ArC (C-5)), 96.9–96.7 (m, CgP quat. C), 75.5
(vir t, JC,P = 13.9 Hz) and 75.3 (vir t, JC,P = 13.9 Hz) (CgP quat.
C), 74.5–74.2 (m, CgP quat. C), 42.9 (m, CgP CH2), 42.4
(m, CgP CH2), 28.0 (s, CgP CH3), 27.8 (s) and 27.7 (s) (CgP
CH3), 27.6 (br s) and 27.5 (br s) (CgP CH3), 26.1 (br s) and 25.9
(br s) (CgP CH3), −1.59 (s) and −1.62 (s) (Si(CH3)3). 31P{1H}
NMR (162 MHz, CD2Cl2): δP −0.8 (s, 1JP,Pt = 2728 Hz) and −1.3
(s, 1JP,Pt = 2647 Hz) (CgP). HRMS (ESI): m/z calc. for
C36H56ClN2O6P2PtSi2 [M − Cl]+ = 960.2484; obs. = 960.2490.
Elem. Anal. found (calc. for C36H56Cl2N2O6P2PtSi2): C, 43.61
(43.37); H, 5.80 (5.66); N, 2.95 (2.81).
[PtCl2(L7b)2] (1h). A solution of L7b (0.040 g, 0.110 mmol) in
CH2Cl2 (1 cm
3) was added to a solution of [PtCl2(cod)]
(0.020 g, 0.053 mmol) in CH2Cl2 (1 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a pale yellow solid
(0.044 g, 83%). rac :meso compounds observed in 1 : 1 ratio.
1H NMR (500 MHz, CD2Cl2): δH 7.96 (d,
3JH,H = 8.0 Hz) and
7.88 (d, 3JH,H = 8.0 Hz) (total 2H, ArH (H-3)), 7.60–7.52 (m, 2H,
ArH (H-4)), 7.48 (d, 3JH,H = 7.4 Hz) and 7.44 (d,
3JH,H = 7.4 Hz)
(total 2H, ArH (H-5)), 3.10–3.04 (m, 2H, CgP CH2), 2.29 (d,
2JH,H =
13.6 Hz) and 2.18 (d, 2JH,H = 13.6 Hz) (total 2H, CgP CH2),
1.87–1.58 (m, 16H, CgP CH3 CH2), 1.36 (s) and 1.33 (s) (total
6H, CgP CH3), 1.26 (s) and 1.25 (s) (total 6H, CgP CH3), 0.33 (s)
and 0.32 (s) (total 18H, Si(CH3)3).
13C{1H} NMR (126 MHz,
CD2Cl2): δC 169.0 (br s) and 168.8 (br s) (ArC (C-6)), 155.1 (s)
and 155.0 (s) (ArC (C-2)), 133.0–132.8 (m, ArC (C-4)), 130.4
(vir t, JC,P = 10.2 Hz) and 130.2 (vir t JC,P = 9.7 Hz) (ArC (C-3)),
128.9 (s) and 128.8 (s) (ArC (C-5)), 96.9–96.8 (m, CgP quat. C),
75.6–75.3 (m) and 74.7–74.3 (m) (CgP quat. C), 42.9 (vir t, JC,P =
3.8 Hz) and 42.8 (vir t, JC,P = 3.9 Hz) (CgP CH2), 42.4 (s) and
42.3 (s) (CgP CH2), 28.0 (s, CgP CH3), 27.8 (s) and 27.7 (s) (CgP
CH3), 27.4 (br s) and 27.3 (br s) (CgP CH3), 26.4 (br s) and 26.3
(br s) (CgP CH3), −1.56 (s) and −1.57 (s) (Si(CH3)3). 31P{1H}
NMR (202 MHz, CD2Cl2): δP −1.6 (s, 1JP,Pt = 2722 Hz) and −1.9
(s, 1JP,Pt = 2724 Hz) (CgP). HRMS (ESI): m/z calc. for
C36H57Cl2N2O6P2PtSi2 [M + H]
+ = 996.2251; obs. = 996.2247.
Elem. Anal. found (calc. for C36H56Cl2N2O6P2PtSi2): C, 43.54
(43.37); H, 5.77 (5.66); N, 3.18 (2.81).
[PtCl2(L3)2] (1i). The solution of L3 (0.020 g, 0.068 mmol)
was added to a solution of [PtCl2(cod)] (0.012 g, 0.034) in
CH2Cl2 (1 cm
3) and the mixture stirred. The reaction was
monitored over 24 hours by 31P NMR spectroscopy (see text for
details).
[PtCl(κ1-L2)(κ2-L2)]BF4 (3[BF4]). AgBF4 (0.003 g, 0.015 mmol)
was added to a CH2Cl2 solution (2 cm
3) of 1a (0.013 g,
0.015 mmol) and stirred overnight. The cloudy mixture was
then filtered through Celite to give a colourless solution,
which was added to hexane to precipitate the product. After
the mixture was allowed to settle, the supernatant was
removed using a pipette and the residual solvent removed
in vacuo to give the product as an oﬀ-white solid (0.010 g,
74%). 1H NMR (400 MHz, CD2Cl2): δH 9.26–9.06 (m, 1H, ArH),
8.84–8.78 (m, 1H, ArH), 8.53–8.48 (m, 1H, ArH), 8.18–8.08 (m,
1H, ArH), 7.97–7.91 (m, 2H, ArH), 7.84 7.78 (m, 1H, ArH),
7.45–7.41 (m, 1H, ArH), 2.47–1.27 (m, 32H, CgP CH3 and CgP
CH2).
11B{1H} NMR (128 MHz, CD2Cl2): δB −2.1 (s, BF4).
19F NMR (377 MHz, CD2Cl2): δF −152.8 (s, BF4). 31P{1H} NMR
(162 MHz, CD2Cl2): δP 0.8 (d,
2JP,P = 11.8 Hz,
1JP,Pt = 3514 Hz,
monodentate CgP), −48.1 (d, 2JP,P = 11.6 Hz, 1JP,Pt = 2947 Hz,
chelate CgP). HRMS (ESI): m/z calc. for C30H40ClN2O6P2Pt [M]
+
= 816.1695; obs. = 816.1691.
[PdCl2(L2)2] (4). A solution of L2 (0.103 g, 0.350 mmol) in
CH2Cl2 (2 cm
3) was added to a solution of [PdCl2(cod)]
(0.050 g, 0.175 mmol) in CH2Cl2 (2 cm
3) and stirred for
24 hours. In air, the product was then precipitated in hexane
(ca. 25 cm3). After the mixture was allowed to settle, the super-
natant was removed using a pipette and the residual solvent
removed in vacuo to give the product as a yellow solid (0.129 g,
96%). rac :meso compounds observed in 1 : 1 ratio. 1H NMR
(500 MHz, CD2Cl2): δH 8.73 (d,
3JH,H = 4.3 Hz) and 8.71 (d,
3JH,H = 4.4 Hz) (total 2H, ArH (H-6)), 8.01 (d,
3JH,H = 4.4 Hz, 2H,
ArH (H-3)), 7.70–7.66 (m, 2H, ArH (H-4)), 7.29 (appq, 3JH,H = 4.4
Hz, 2H, ArH (H-5)), 3.04 (d of vir t, 2JH,H = 13.6 Hz, JH,P = 2.3
Hz) and 2.96 (d of vir t, 2JH,H = 13.6 Hz, JH,P = 2.3 Hz) (total 2H,
CgP CH2), 2.24 (s) and 2.35 (s) (total 1H, CgP CH2), 1.99–1.89
(m, 3H, CgP CH2), 1.84 (vir t, JH,P = 6.3 Hz) and 1.80 (vir t,
JH,P = 6.3 Hz) (total 6H, CgP CH3), 1.73 (vir t, JH,P = 6.8 Hz) and
1.70 (vir t, JH,P = 6.6 Hz) (total 6H, CgP CH3), 1.59–1.54 (m, 2H,
CgP CH2), 1.38 (s) and 1.35 (s) (total 6H, CgP CH3), 1.27 (s, 6H,
CgP CH3).
13C{1H} NMR (126 MHz, CD2Cl2): δC 155.6 (vir t, JC,P
= 30.4 Hz) and 156.0 (vir t, JC,P = 29.7 Hz) (ArC (C-2)), 150.1
(app q, JC,P = 8.0 Hz, ArC (C-6)), 135.4 (br s, ArC (C-4)), 131.1
(vir t, JC,P = 8.7 Hz) and 130.1 (vir t, JC,P = 8.2 Hz) (ArC (C 3)),
124.5 (s, ArC (C-5)), 97.0–96.8 (m, CgP quat. C), 76.3 (vir t,
JC,P = 10.9 Hz) and 76.2 (vir t, JC,P = 10.8 Hz) (CgP quat. C), 75.0
(vir t, JC,P = 7.1 Hz) and 74.8 (vir t, JC,P = 7.0 Hz) (CgP quat. C),
43.2–43.1 (m, CgP CH2), 42.5–42.4 (m, CgP CH2), 28.2 (br s)
and 28.1 (br s) (CgP CH3), 27.8 (s, CgP CH3), 27.73 (s) and
27.68 (s) (CgP CH3), 26.8 (vir t, JC,P = 2.5 Hz) and 26.6 (vir t,
JC,P = 2.7 Hz) (CgP CH3).
31P{1H} NMR (162 MHz, CD2Cl2):
δP 4.4 (s) and 4.3 (s) (CgP). HRMS (ESI): m/z calc. for
C30H40ClN2O6P2Pd [M − Cl]+ = 727.1088; obs. = 727.1103.
Elem. Anal. found (calc. for C30H40Cl2N2O6P2Pd): C, 47.16
(47.17); H, 5.29 (5.28); N, 3.85 (3.67).
[PdCl(κ1-L2)(κ2-L2)]BF4 (5[BF4]). AgBF4 (0.008 g, 0.039 mmol)
was added to a CH2Cl2 solution (3 cm
3) of 4 (0.030 g,
0.039 mmol) and stirred overnight. The cloudy mixture was
then filtered through Celite to give a yellow solution, which
was added to hexane to precipitate the product. After the
mixture was allowed to settle, the supernatant was removed
using a pipette and the residual solvent removed in vacuo to
give the product as a yellow solid (0.024 g, 76%). Crystals suit-
able for X-ray diﬀraction were grown by slow evaporation of a
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CH2Cl2 solution of the product.
1H NMR (500 MHz, CD2Cl2):
δH 8.92–8.89 (m, 1H, ArH), 8.79–8.78 (m, 1H, ArH), 8.41–8.36
(m, 1H, ArH), 8.06–8.02 (m, 2H, ArH), 7.87–7.79 (m, 2H, ArH),
7.79–7.47 (m, 1H, ArH), 2.43–1.27 (m, 32H, CgP CH3 and CgP
CH2).
11B{1H} NMR (128 MHz, CD2Cl2): δB −2.2 (s, BF4).
19F NMR (377 MHz, CD2Cl2): δF −152.8 (s, BF4). 31P{1H} NMR
(121 MHz, CD2Cl2): δP 28.8 (br s, monodentate CgP), −42.1 (d,
2JP,P = 3.2 Hz, chelate CgP).
31P{1H} NMR (121 MHz, CD2Cl2,
−90 °C): δP 28.8 (d, 2JP,P = 3.2 Hz, monodentate CgP), −42.0
(br s, chelate CgP). HRMS (ESI): m/z calc. for
C30H40ClN2O6P2Pd [M]
+ = 727.1088; obs. = 727.1118. Elem.
Anal. found (calc. for C30H40BClF4N2O6P2Pd·CH2Cl2): C, 41.79
(41.36); H, 4.86 (4.70); N, 3.20 (3.11) (the presence of CH2Cl2
was confirmed by 1H NMR spectroscopy and was observed
in the crystal structure).
Protonation studies
TsOH·H2O (0.003 g, 0.015 mmol) was added to a suspension
of 4 (0.010 g, 0.013 mmol) in CD2Cl2 (0.7 cm
3), upon which
the solution became homogeneous, yielding species assigned
to the protonated species 6. 31P{1H} NMR (121 MHz, CD2Cl2):
δP 6.0 (br s, CgP) and 3.7 (br s, CgP). An analogous procedure
in MeOH (0.7 cm3) also gave a homogenous solution, assigned
to be a mixture of 6 and a P,N-chelate species related to 5[OTs].
31P{1H} NMR (121 MHz, CD2Cl2): δP 28.8 (br s, monodentate
CgP), 6.3 (br s, CgP) and 4.5 (br s, CgP), −42.2 (br s, chelate
CgP).
Phenylacetylene methoxycarbonylation
Adapted from previously reported procedure.9 Catalysis was
performed using a Baskerville Multi-Cell autoclave. The ligand
(0.11 mmol) was added to the autoclave and the system put
under an atmosphere of N2. Solutions of Pd(OAc)2
(0.0055 mmol) in MeOH (0.5 cm3) and TsOH·H2O (0.22 mmol)
in MeOH (0.5 cm3) were then added, followed by phenyl-
acetylene (5.5 mmol). This was then washed in using MeOH
(0.5 cm3) and the autoclave flushed with three cycles of CO (ca.
10 bar). The autoclave was then pressurised to 45 bar and
heated to 60 °C. After 1 hour or 4.5 hours, the autoclave was
transferred to an ice bath and once cooled, the system was
vented. A small amount of each sample was dissolved in CDCl3
and analysed by 1H NMR spectroscopy. Conversion and selecti-
vity was determined by integration of the phenylacetylene
alkynyl proton (δH 3.10 ppm) and the methyl atropate (δH 6.38
and 5.90 ppm) and methyl cinnamate (δH 7.71 and 6.42 ppm)
alkenyl protons.
X-ray crystallography
All of the X-ray diﬀraction data were collected at 100 K on a
Bruker Apex II diﬀractometer with CCD area detector using
Mo-Kα radiation (λ = 0.71073 Å). Absorption corrections were
carried out using SADABS.25 All of the structures were solved
using Superflip26,27 and refined by full matrix least squares on
F2 using ShelXL28,29 within Olex2.30 The structure of meso-1g
displayed disorder in the cage, the occupancies of the dis-
ordered atoms were refined with the sum of the occupancies
set to 1 before being fixed at the refined values. Restraints
were applied to the bond lengths and the thermal parameters
of pairs of disordered atoms on almost the same site were con-
strained to be equal. The structure of 5 was twinned and
refined as a 2-component twin. In addition, the BF4
− counter-
ion displayed disorder in the fluorine positions, the sum of
the occupancies were set to equal 1 and refined before being
fixed at the refined values. Restraints were applied to maintain
sensible thermal parameters and B–F distances. Crystal struc-
ture and refinement details are given in Tables S1–S3 in ESI.†
Crystallographic data for the compounds have been deposited
with the Cambridge Crystallographic Data Centre as sup-
plementary publication, CCDC 1497885–1497898.
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